Originally developed for the management of type 2 diabetes, semaglutide has also shown promise in the field of weight management
Since semaglutide is a pure agonist of the GLP-1 receptor, it exclusively stimulates the phenomena controlled by this receptor, while the ability of tirzepatide to act simultaneously on the GLP-1 and GIP receptors enables the activation of all the processes mediated by these incretins (Figure 3)
Upcoming Giants (in people being less giant) Although there are many other GLP1R agonists in the pipeline across many companies, some of the few standout drugs, in terms of body weight loss efficacy, are worth noting in brief
The full steady-state level takes about three to four weeks to re-establish after any significant disruption, but the functional effects of each individual dose begin much sooner
Focusing on Health Rather Than the Scale You have likely started your weight loss process with a specific goal in mind for your weight loss